Search hospitals > Florida > Fort Lauderdale

UM Sylvester Comprehensive Cancer Center at Plantation

Claim this profile
Fort Lauderdale, Florida 33324
Global Leader in Cancer
Global Leader in Recurrence
Conducts research for Lung Cancer
Conducts research for Breast Cancer
Conducts research for Melanoma
93 reported clinical trials
40 medical researchers
Photo of UM Sylvester Comprehensive Cancer Center at Plantation in Fort LauderdalePhoto of UM Sylvester Comprehensive Cancer Center at Plantation in Fort LauderdalePhoto of UM Sylvester Comprehensive Cancer Center at Plantation in Fort Lauderdale

Summary

UM Sylvester Comprehensive Cancer Center at Plantation is a medical facility located in Fort Lauderdale, Florida. This center is recognized for care of Cancer, Recurrence, Lung Cancer, Breast Cancer, Melanoma and other specialties. UM Sylvester Comprehensive Cancer Center at Plantation is involved with conducting 93 clinical trials across 204 conditions. There are 40 research doctors associated with this hospital, such as Jose Lutzky, MD, Marilyn Huang, Macarena I. De La Fuente, and Chukwuemeka (Emeka) V. Ikpeazu.

Area of expertise

1Cancer
Global Leader
UM Sylvester Comprehensive Cancer Center at Plantation has run 47 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage I
2Recurrence
Global Leader
UM Sylvester Comprehensive Cancer Center at Plantation has run 18 trials for Recurrence. Some of their research focus areas include:
Stage IV
Stage III
IDH positive

Top PIs

Clinical Trials running at UM Sylvester Comprehensive Cancer Center at Plantation

Breast Cancer
Melanoma
Cancer
Squamous Cell Carcinoma
Non-Small Cell Lung Cancer
Cutaneous Melanoma
Lung Cancer
Skin Cancer
Gallbladder Cancer
Recurrence
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Image of trial facility.

T-DM1 + Tucatinib

for Breast Cancer

This study is evaluating whether a combination of two drugs may help prevent breast cancer from coming back.
Recruiting1 award Phase 313 criteria
Image of trial facility.

Targeted Therapy

for Solid Tumors

This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.
Recruiting1 award Phase 217 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at UM Sylvester Comprehensive Cancer Center at Plantation?
UM Sylvester Comprehensive Cancer Center at Plantation is a medical facility located in Fort Lauderdale, Florida. This center is recognized for care of Cancer, Recurrence, Lung Cancer, Breast Cancer, Melanoma and other specialties. UM Sylvester Comprehensive Cancer Center at Plantation is involved with conducting 93 clinical trials across 204 conditions. There are 40 research doctors associated with this hospital, such as Jose Lutzky, MD, Marilyn Huang, Macarena I. De La Fuente, and Chukwuemeka (Emeka) V. Ikpeazu.